MedPath

Ayurvedic medicine in the management of blurred vision

Phase 4
Not yet recruiting
Conditions
Unspecified visual disturbance. Ayurveda Condition: TIMIRAH,
Registration Number
CTRI/2022/11/047345
Lead Sponsor
Dr Srinidhi S
Brief Summary

Globally, 2.2 billion people have distance vision impairment.The prevalence of myopia in 5 to 15 years old urban children increased from 4.44% in 1999 to 21.15% in 2019. Myopia is a commonest clinical condition in which the refracted light spectrum from all possible direction forms an image before / in front of retina. This situation induces blurry vision & related clinical features.Concept of Refractive Errors nearly correlates with *Timira*. It is a conduction explained in classics starting from minimal visual blurriness to visual hallucinations, delusions, abrasions, etc. Spectacles, contact lenses, Ortho-optic treatment, few medications, suppliments and surgical intervention are treatment options available. Various systemic and local therapies in the form of *Kriyakalpa* procedures like *Aschyotana, Seka, Anjana,* etc are explained for vision enhancement.*Nayana Sukha Varti* is a classical formulation of *Anjana*from *Bhaishajya Ratnavali* indicated in *Timira*. In Anjana procedure, it is advised to rub Varti with suitable media and applied from medial to lateral canthus with various metallic applicator.This leads to controversy in its sterility, stability, utility, therapeutic efficacy, application method, applicator, storage method, etc. In such scenario there is a need of safe and sterile form of medication without compromising pharmaceutical as well as clinical values. Thus this new technique of Anjana preparation checks out the challenging hurdles in Anjana practices. This modified form of Anjana preparation should be equivalent and competent to modern opthalmic preparations.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

a SUBJECTS HAVING REFRACTIVE ERROR WITHIN -3 D b SUBJECTS OF EITHER SEX c FROM 16 YEARS TO 25 YEARS OF AGE.

Exclusion Criteria

a ANY ALLERGIC CONDITIONS b METABOLIC DISORDERS c ANY SEVERE EYE AILMENTS.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
VISUAL ACUITY LOG MAR REFRACTIONBaseline and 21st day
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

KAHERS Shri B M Kankanwadi Ayurveda Mahavidyalaya Shahapur Belagavi

🇮🇳

Belgaum, KARNATAKA, India

KAHERS Shri B M Kankanwadi Ayurveda Mahavidyalaya Shahapur Belagavi
🇮🇳Belgaum, KARNATAKA, India
Dr Srinidhi S
Principal investigator
6380238349
srinidhi.janani@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.